Walleye Trading LLC Tg Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $215,125 - $316,000	12,500 Added 85.03%	27,200 $636,000
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $61,272 - $88,274	-4,600 Reduced 23.83%	14,700 $261,000
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $100,254 - $164,010	-7,700 Reduced 28.52%	19,300 $293,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $17,368 - $48,906	2,600 Added 10.66%	27,000 $461,000
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $84,436 - $267,650	10,100 Added 70.63%	24,400 $203,000
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $147,060 - $332,500	-9,500 Reduced 39.92%	14,300 $355,000
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $103,323 - $195,334	10,100 Added 73.72%	23,800 $357,000
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $241,983 - $571,389	-48,300 Reduced 77.9%	13,700 $162,000
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $210,220 - $386,400	46,000 Added 287.5%	62,000 $367,000
Q2 2022 Aug 08, 2022	BUY	$3.74 - $10.66 $59,840 - $170,560	16,000 New	16,000 $68,000
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $90,596 - $237,220	-11,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $39,520 - $92,326	2,600 Added 28.89%	11,600 $220,000
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $106,722 - $198,205	4,900 Added 119.51%	9,000 $300,000
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $133,250 - $200,736	4,100 New	4,100 $159,000
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $312,075 - $407,250	-7,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $189,525 - $411,750	7,500 New	7,500 $390,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.